Board of Directors  
Clinical and Scientific Advisory Board  
Historical Background  

Board of Directors

Back row left to right: Jean De Serres, Adriano Fontana, Manfred Heule. Front row left to right: Claude Blum, Grazia Maion, David Deperthes, Henrik Heegaard

David Deperthes, Ph.D. – CEO and President
Founder and CEO of Med Discovery, Dr. Deperthes obtained his Ph.D. in Molecular and Cellular Biology from Laval University in Canada. Discoverer of a new prostate cancer marker, the kallikrein hK2, with Prof. Rolland R. Tremblay, he specialized in the development of new molecules for tumor targeting with J.P. Mach at the ISREC in Lausanne. Dr. Deperthes was Director of the Urology Research Unit at the University Hospital of Lausanne for 5 years. He won the NETS’ Prize in 2003 which consists of an intensive business and management training given at Babson College in Boston to a young entrepreneur selected by the NETS’ prize committee. Dr. Deperthes is also involved in different committees and associations such as Venturekick, Bioalps, or the Swiss Biotech Association.

Claude Blum, Dr. iur., M.C.L.
Claude Blum obtained his Dr. iur. at Zürich University Law School, he then received a Master of Comparative Law from Southern Methodist University Law School, Dallas, Tx, he was admitted to the Bar in Zürich in 1984. He is a partner with Blum&Grob Attorneys at Law Zurich/Switzerland.

Professor Adriano Fontana, PhD
Professor Adriano Fontana, is a graduate from the University of Zürich (1976) where he currently is Prof. Ordinarius of Clinical Immunology and Director of the Immunology Clinic of the University Hospital. A specialist of immunology of the central nervous system, he authored more than 220 original scientific publications. Member of various Editorial and Foundation Boards he received several prices for his outstanding scientific work. He also hold 3 international patents.
Photo courtesy of University of Zurich, Heike Grasser

Manfred Heule (CPA)
Manfred Heule is the CEO and owner of a tax- and business-consulting company in Zurich. As a former partner of one of the “big five” audit companies, a former extraordinary member of a cantonal tax appeal commission and a member of the International Fiscal Association (IFA) he has a wide experience in accounting, finances and taxes.

Grazia Maion, PhD, MBA
Grazia Maion holds a PhD degree in Microbiology Immunology (1995) and a Master degree in Microbiology Immunology (Oncology). In 2003, she also obtained an executive MBA from University of Quebec at Montreal (UQAM). Prior joining the Solidarity Fund QFL as Senior Advisor, Investments, Life Sciences group in September 2001, Dr. Maion has worked as a Technology Transfer Agent at UQAM and within the Commercial Operations and the Clinical Research Group at GlaxoWellcome Inc.

Jean De Serres, MD, MSc, MBA, Chairman of Clinical and Scientific Advisory Board
Dr. De Serres holds a MD and M.Sc from University of Montreal and a MBA in bioindustries from UQAM. At the beginning of his carreer, he practiced medicine and was Director of teaching unit at McGill University as well as President of the Quebec College of Family Physicians. He has also acted as Director of Public Health in Hull, QC prior to joining Aventis Behring Canada as Medical Director and then as General Manager. He is now VP Clinical Research and Regulatory Affairs at Draximage (a division of Draxis Specialty Pharmaceuticals Inc).